Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 21 March 2025 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2024 and resolved to discharge the members of… Continue reading Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
Tag: M and A
Faruqi & Faruqi Reminds AppLovin Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 – APP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AppLovin To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in AppLovin between May 10, 2023 to February 25, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh… Continue reading Faruqi & Faruqi Reminds AppLovin Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 – APP
Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 21 March 2025 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2024 and resolved to discharge the members of… Continue reading Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
Kalyani Powertrain partners with AMD to strengthen India’s server infrastructure
Kalyani Powertrain’s partnership with AMD will introduce advanced EPYC-based server technologies to India, strengthening the country’s data infrastructure. The electronics division of Kalyani Powertrain, a wholly-owned subsidiary of Bharat Forge, has formed a partnership with AMD (Advanced Micro Devices) to enter the Indian server market. This collaboration represents a significant step in advancing India’s server… Continue reading Kalyani Powertrain partners with AMD to strengthen India’s server infrastructure
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
Announced merger agreement with Cullgen in November, anticipated to close in the first half of 2025 As part of proposed merger, Pulmatrix intends to divest its assets including its Phase 2-ready acute migraine candidate, PUR3100, and other development candidates based on its iSPERSE™ technology FRAMINGHAM, Mass., March 21, 2025 /PRNewswire/ — Pulmatrix, Inc. (“Pulmatrix” or the… Continue reading Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
Levitate Named a 2025 Top Workplace by USA TODAY
RALEIGH, N.C., March 21, 2025 /PRNewswire/ — Levitate is proud to announce its recognition as a 2025 Top Workplace by USA TODAY, a prestigious award that highlights the company’s unwavering commitment to fostering a dynamic, inclusive, and innovative workplace culture. Continue Reading Levitate Recognized on USA TODAY Top Workplaces 2025 List. Each year, USA TODAY’s Top… Continue reading Levitate Named a 2025 Top Workplace by USA TODAY
Syneron Bio Announces Strategic Collaboration with AstraZeneca
BEIJING, March 21, 2025 /PRNewswire/ — Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader AstraZeneca to develop potential first-in-class macrocyclic peptides for the treatment of chronic diseases. Under this collaboration, AstraZeneca will gain access to Syneron Bio’s innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development… Continue reading Syneron Bio Announces Strategic Collaboration with AstraZeneca
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure Data from Multiple Ongoing Late-Stage Studies Reinforce Brii Bio’s HBV Functional Cure Strategy of Optimized Combination Regimens to Target Patient Populations 4 Abstracts Including 2 Oral Presentations with Data from the Ongoing… Continue reading Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
13 Press Releases You Need to See This Week
Including the return of NASA’s Crew-9 astronauts, PepsiCo’s acquisition of poppi and Vrbo’s top vacation rentals of the year. NEW YORK, March 21, 2025 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the… Continue reading 13 Press Releases You Need to See This Week
China Yuchai Subsidiary Adopts Equity Incentive Plan
SINGAPORE, March 21, 2025 /PRNewswire/ — China Yuchai International Limited (NYSE: CYD) (“China Yuchai” or the “Company“) one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery Company Limited (“Yuchai“), today announced an equity incentive plan was approved by the shareholders of Yuchai and implemented today by Guangxi… Continue reading China Yuchai Subsidiary Adopts Equity Incentive Plan